Loading clinical trials...
Loading clinical trials...
Phase II Study of Single-Agent Cetuximab for Treatment of High-Risk Pre-malignant Upper Aerodigestive Lesions
Conditions
Interventions
cetuximab
Locations
10
United States
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
University of Chicago Cancer Research Center
Chicago, Illinois, United States
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky, United States
Greenebaum Cancer Center at University of Maryland Medical Center
Baltimore, Maryland, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
Start Date
May 1, 2007
Primary Completion Date
December 1, 2011
Completion Date
December 1, 2011
Last Updated
March 12, 2020
NCT07209189
NCT06477692
NCT04585750
NCT06636188
NCT07457346
NCT04915183
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions